Esprit Capital Partners leads €15m Kiadis funding round
Kiadis Pharma, the biotech company backed by European venture capital firm Esprit Capital Partners, has raised €15 million in its latest funding round.
ByJo Nash
4 January 2013•1 min read
Kiadis Pharma, the biotech company backed by European venture capital firm Esprit Capital Partners, has raised €15 million in its latest funding round.
